---
figid: PMC7642854__AJ-AEND200010F003
figtitle: 'Endothelial dysfunction due to selective insulin resistance in vascular
  endothelium: insights from mechanistic modeling'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7642854
filename: AJ-AEND200010F003.jpg
figlink: /pmc/articles/PMC7642854/figure/F0003/
number: F3
caption: Complete model of insulin signaling pathways stimulating nitric oxide (NO)
  and endothelin-1 (ET-1) production in endothelial cells with feedback and cross-talk.
  Insulin binding to its receptor results in receptor autophosphorylation and the
  phosphorylation of insulin receptor substrate (IRS-1) by the insulin receptor tyrosine
  kinase. Phosphorylated IRS-1 activates phosphatidylinositol 3-kinase (PI3K), which
  increases membrane-bound PI(3,4,5)P3 (PIP3). PIP3 recruits and activates 3-phosphoinositide-dependent
  protein kinase-1 (PDK-1), which phosphorylates and activates Akt and atypical PKCs.
  Activated Akt phosphorylates endothelial nitric oxide synthase (eNOS) to increase
  nitric oxide (NO), a vasodilator. Tyrosine phosphorylation of the insulin receptor
  (IR) also increases the association of Shc and Grb2 to the IR, leading to the activation
  of the Ras‐Raf‐MEK‐MAPK1/2 cascade. MAPK increases the production of ET-1, a vasoconstrictor.
  Positive and negative feedback pathways are indicated by dotted lines. Cross talk
  between the PI3K and MAPK branches is indicated (-˙˙-˙˙-). Atypical PKC serine phosphorylates
  IRS-1 to create a negative feedback pathway, and Akt phosphorylates PTP1B to create
  a positive feedback pathway. Akt directly phosphorylates and attenuates Raf activity
  to create crosstalk between the PI3K-Akt-NO and MAPK-ET-1 pathways. Under healthy
  conditions, insulin stimulated vasodilation counteracts the vasoconstrictive effects
  of insulin-stimulated ET-1.
papertitle: 'Endothelial dysfunction due to selective insulin resistance in vascular
  endothelium: insights from mechanistic modeling.'
reftext: Ranganath Muniyappa, et al. Am J Physiol Endocrinol Metab. 2020 Sep 1;319(3):E629-E646.
year: '2020'
doi: 10.1152/ajpendo.00247.2020
journal_title: American Journal of Physiology - Endocrinology and Metabolism
journal_nlm_ta: Am J Physiol Endocrinol Metab
publisher_name: American Physiological Society
keywords: endothelin-1 | endothelium | insulin signaling | mathematical modeling |
  nitric oxide
automl_pathway: 0.9272162
figid_alias: PMC7642854__F3
figtype: Figure
redirect_from: /figures/PMC7642854__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7642854__AJ-AEND200010F003.html
  '@type': Dataset
  description: Complete model of insulin signaling pathways stimulating nitric oxide
    (NO) and endothelin-1 (ET-1) production in endothelial cells with feedback and
    cross-talk. Insulin binding to its receptor results in receptor autophosphorylation
    and the phosphorylation of insulin receptor substrate (IRS-1) by the insulin receptor
    tyrosine kinase. Phosphorylated IRS-1 activates phosphatidylinositol 3-kinase
    (PI3K), which increases membrane-bound PI(3,4,5)P3 (PIP3). PIP3 recruits and activates
    3-phosphoinositide-dependent protein kinase-1 (PDK-1), which phosphorylates and
    activates Akt and atypical PKCs. Activated Akt phosphorylates endothelial nitric
    oxide synthase (eNOS) to increase nitric oxide (NO), a vasodilator. Tyrosine phosphorylation
    of the insulin receptor (IR) also increases the association of Shc and Grb2 to
    the IR, leading to the activation of the Ras‐Raf‐MEK‐MAPK1/2 cascade. MAPK increases
    the production of ET-1, a vasoconstrictor. Positive and negative feedback pathways
    are indicated by dotted lines. Cross talk between the PI3K and MAPK branches is
    indicated (-˙˙-˙˙-). Atypical PKC serine phosphorylates IRS-1 to create a negative
    feedback pathway, and Akt phosphorylates PTP1B to create a positive feedback pathway.
    Akt directly phosphorylates and attenuates Raf activity to create crosstalk between
    the PI3K-Akt-NO and MAPK-ET-1 pathways. Under healthy conditions, insulin stimulated
    vasodilation counteracts the vasoconstrictive effects of insulin-stimulated ET-1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - inc
  - insc
  - InR
  - norpA
  - Shc
  - fh
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - MKP-4
  - p38b
  - rl
  - l(3)X27
  - Raf
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Mkp3
  - Ptp61F
  - x2
  - x8
  - fig
  - rdgA
  - ps
  - Cyp4p2
  - Akt
  - net
  - Neto
  - NetA
  - NetB
  - x16
  - x10
  - l(3)X12
  - Pten
  - X11L
  - nonA
  - arg
  - aos
  - INS
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - FXN
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTG1
  - PTPA
  - DUSP6
  - PTPN1
  - DEPP1
  - GOPC
  - EDN1
  - IRS1
  - PI3
  - ZNF717
  - AKT1
  - AKT2
  - AKT3
  - ELK3
  - EPHB1
  - SLC6A2
  - XG
  - INPP5D
  - NOS3
  - ENO4
  - PTEN
  - APBA1
  - SERPINA4
  - ABL2
  - RERE
---
